1. Coronavirus disease 2019: A new severe acute respiratory syndrome from Wuhan in China. Y. CAO, K. CAI, L. XIONG. Acta virologica 64: 245– 250, 2020
2. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine Wanbo Tai, Lei He, Xiujuan Zhang, Jing Pu, Denis Voronin, Shibo Jiang, Yusen Zhou and Lanying Du. Cellular & Molecular Immunology (2020) 17:613–620; https://doi.org/10.1038/s41423-020-0400-4
3. Новая коронавирусная инфекция (COVID-19): клинико-эпидемиологические аспекты. В.В. Никифоров, Т.Г. Суранова, Т.Я. Чернобровкина, Я.Д. Янковская, С.В. Бурова. Архивъ внутренней медицины № 2 2020 [Novel coronavirus infection (COVID-19): clinical and epidemiological aspects. V.V. Nikiforov, T.G. Suranova, T.Ja. Chernobrovkina, Ja.D. Jankovskaja, S.V. Burova. Arhiv vnutrennej mediciny № 2 2020 (in Russ.)].
4. Gastroenterology. 2020 May; 158(6): 1518–1519. Published online 2020 Mar. COVID-19: Gastrointestinal Manifestations and Potential Fecal–Oral Transmission. Jinyang Gu, Bing Han, and Jian Wang
5. Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract. Jaewon J. Lee, Scott Kopetz, Eduardo Vilar, John Paul Shen, Ken Chen and Anirban Maitra. Genes 2020 june; 11 (6): 645
6. Коронавирусная инфекция COVID-2019. Б. К. Романов. Безопасность и риск фармакотерапии 2020. Т. 8, № 1. [Coronavirus infection COVID-2019. B. K. Romanov. Bezopasnost' i risk farmakoterapii 2020. T. 8, № 1 (in Russ.)].
7. Gastroenterology Practis in COVID-19 Pandemic. Lu Xia, Kaichun Wu. E-WGO
8. COVID-19 и поражение печени. Ильченко Л.Ю., Никитин И.Г., Федоров И.Г. Архив внутренней медицины. 2020;10(3):188-197 [COVID-19 and liver damage. Il'chenko L.Ju., Nikitin I.G., Fedorov I.G. Arhiv vnutrennej mediciny. 2020;10(3):188-197 (in Russ.)].
9. Инфекция COVID-19 и органы пищеварения. Д.С. Бордин, М.А. Кирюкова, М.И. Шенгелия,С.В. Колбасников. Эффективная фармакотерапия. 2020. Том 16. № 1 [COVID-19 infection and digestive organs. D.S. Bordin, M.A. Kirjukova, M.I. Shengelija,S.V. Kolbasnikov. Jeffektivnaja farmakoterapija. 2020. Tom 16. № 1 (in Russ.)].
10. Jin X., Lian JS, Hu JH, Gao J., Zheng L., Zhang YM, Hao SR, Jia HY, Cai H., Zhang XL. Epidemiological, clinical and virological characteristics of 74 cases of the disease infected with coronavirus 2019 (COVID-19) with gastrointestinal symptoms. Intestine, 2020; 69: 1002-1009
11. Mart M. Lamers, Joep Beumer, Jelte van der Vaart et al. SARS-CoV-2 productively infects human gut enterocyte. Science 03 Jul 2020
12. Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome. SONIA VILLAPOL, 2020
13. Don’t Overlook Digestive Symptoms in Patients With Novel Coronavirus Diseas (Covid-19). Shihua Luo, Xiaochun Zhang and Halido Xu. Clinical Gastroenterology and Hepatology 2020;18:1636–1637
14. D’Amico F, Baumgart DC, Danese S, Peyrin-Biroulet L. Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention, and management. Clin Gastroenterol Hepatol 2020;18:1663–7
15. Pan L, Mu M, Yang P, et al. Clinical characteristics of COVID- 19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroen- terol. 2020;115:766–73
16. Lin L., Jiang X., Zhang Z., Huang S., Zhang Z., Fang Z., al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut. 2020; 69(6):997–1001 DOI: 10.1136/gutjnl-2020-321013
17. Parasa S, Desai M, Thoguluva Chandrasekar V, et al. Prevalence of gastrointestinal symptoms and fecal viral shedding in patients with Coronavirus disease 2019: a systematic review and meta-analysis. JAMA Netw Open 2020;3:e2011335
18. Song Y., Liu P., Shi X.L., Chu J.L., Zhang J., Xia J., et al. SARS-CoV-2 induced diarrhea as onset symptom in patient with COVID-19. Gut. 2020;69(6):1143–44. DOI: 10.1136/gutjnl-2020-320891
19. First Case of 2019 Novel Coronavirus in the United States. The New England Journal of Medicine. March 5, 2020
20. COVID-19 Disease With Positive Fecal and Negative Pharyngeal and Sputum Viral Tests. Lijuan Chen, Jianghua Lou, Yan Bai and Meiyun Wang. Am J Gastroenterol 2020;115:790
21. Zhang J, Wang S, Xue Y. Fecal specimen diagnosis 2019 novel coronavirus-infected pneumonia. J Med Virol. 2020. https ://doi. org/10.1002/jmv.25742
22. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020. https ://doi.org/10.1053/j.gastr o.2020.02.055
23. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Tatsuo Hashimoto , Thomas Perlot. Nature 2012 Jul 25;487(7408):477-81)
24. Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak. Published Online March 25, 2020 https://doi.org/10.1016/ S2468-1253(20)30085-6
25. Mazza S., Sorce A., Peyvandy F., Vecchi M., Cap- rioli F. A fatal case of COVID-19 pneumonia occurring in a patient with severe acute ulcerative colitis. Gut. 2020;69(6):1148–49. DOI: 10.1136/gutjnl-2020-321183
26.https://www.crohnscolitisfoundation.org/coronavirus/ibd-medication
27. Rubin D.T., Abrey M.T., Rai V., Siegel C.A. Interna- tional Organization for the Study of Inflammatory Bowel Disease. Management of Patients with Crohn’s Disease and Ulcerative Colitis During the COVID-19 Pandemic: Results of an International Meeting. Gastroenterology. 2020; S0016-5085(20)30465-0. DOI: 10.1053/j.gas- tro.2020.04.002
28.https://www.crohnscolitisfoundation.org/coronavirus/ibd-medication